抗生素合理应用1教学教材.pptVIP

* * * * * * Development of High Prevalence of Resistance in Clinically Important Pathogens Methicillin-resistant staphylococci: 1. Vancomycin has become the drug of choice for treating MRSA infections1 2. Reports of strains of MRSA with intermediate resistance to glycopeptides may signify the development of strains with higher levels of resistance to vancomycin.1-3 GISA strains are generally associated with previous MRSA infections, repeated, prolonged use of vancomycin, and dialysis therapy2 Vancomycin-resistant enterococci: 1. Vancomycin-resistant enterococci accounted for nearly